Drawing Strength from Victory 14.05.2021Eyewitnesses have said and written a lot about the events of the Great Patriotic War, about the ordeals suffered by the people. Every family has at least one story from this tragic period in our country’s life. On the threshold of Victory Day, let us look through the memories of those who led the military operations, and read the Marshals’ memoirs.
EpiVacCorona protects the elderly from coronavirus by 94%/ Главная / Russkiy Mir Foundation / News / EpiVacCorona protects the elderly from coronavirus by 94%
EpiVacCorona protects the elderly from coronavirus by 94%
Photo credit: M. Mishin. Press service of the Mayor and Government of Moscow / mos.ru (CC BY 4.0)
Vaccination with EpiVacCorona among the elderly leads to the development of antibodies in 94% of cases, RIA Novosti reports.
The Vector center, which developed the drug, was assured that it can be used for all age categories over 18 years old. Now the center is studying the issue of using the drug for younger people.
EpiVacCorona, made on the basis of peptide antigens, was registered by the Vector Center from Novosibirsk in mid-October. It demonstrated 100% efficiency.
The vaccine is characterized by the highest degree of safety due to the technology of its production. There is no live virus in it, it forms antiviral immunity through the use of artificially synthesized peptides.
It clarifies that the drug has 100% effectiveness against severe cases of COVID-19 and hospitalization. Also, the results of the analysis say that the volunteers who were vaccinated did not have severe cases of COVID-19, the drug itself was well tolerated.